Herbert Loong, Chair-Elect of the International Affairs Committee at ASCO, shared a post on LinkedIn:
“And that’s a wrap! Thanks to my co-investigators and colleagues at D3 Bio for giving me the opportunity to present our data on D3S-001, a novel KRASG12C compound with rapid and efficient target engagement and efficacy showing significant activity in KRASG12ci pre-treated NSCLC.”
More posts featuring Herbert Loong.
